Intellia Therapeutics (NTLA) EV to CFO (2016 - 2017)
Intellia Therapeutics' (NTLA) EV to CFO stood at 7.33 in Q1 2017.
Powered by 
Analysis
Intellia Therapeutics (NTLA) EV to CFO (2016 - 2017) Analysis & Trends
On a TTM basis, Intellia Therapeutics' EV to CFO came in at -18.00 as of Mar 31, 2017; for FY2016, it was 0.51.
- Per Business Quant, the preceding three quarters came in at 0.51 (Q4 2016), 7.15 (Q3 2016) and 2.18 (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Intellia Therapeutics | 1.68 Bn | 1.68 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 7.33 |
| Dec 31, 2016 | 0.51 |
| Sep 30, 2016 | 7.15 |
| Jun 30, 2016 | 2.18 |
API Access
Intellia Therapeutics EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();